SMT202100390T1 - Metodi migliorati per l'acilazione di maytansinolo - Google Patents

Metodi migliorati per l'acilazione di maytansinolo

Info

Publication number
SMT202100390T1
SMT202100390T1 SM20210390T SMT202100390T SMT202100390T1 SM T202100390 T1 SMT202100390 T1 SM T202100390T1 SM 20210390 T SM20210390 T SM 20210390T SM T202100390 T SMT202100390 T SM T202100390T SM T202100390 T1 SMT202100390 T1 SM T202100390T1
Authority
SM
San Marino
Prior art keywords
maytansinol
acylation
improved methods
methods
improved
Prior art date
Application number
SM20210390T
Other languages
English (en)
Italian (it)
Inventor
Robert Yongxin Zhao
Wayne C Widdison
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of SMT202100390T1 publication Critical patent/SMT202100390T1/it

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01RELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R12/00Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
    • H01R12/50Fixed connections
    • H01R12/51Fixed connections for rigid printed circuits or like structures
    • H01R12/55Fixed connections for rigid printed circuits or like structures characterised by the terminals
    • H01R12/58Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
    • H01R12/585Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/02Details
    • H05K1/0201Thermal arrangements, e.g. for cooling, heating or preventing overheating
    • H05K1/0203Cooling of mounted components
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/02Details
    • H05K1/11Printed elements for providing electric connections to or between printed circuits
    • H05K1/115Via connections; Lands around holes or via connections
    • H05K1/116Lands, clearance holes or other lay-out details concerning the surrounding of a via
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/18Printed circuits structurally associated with non-printed electric components
    • H05K1/181Printed circuits structurally associated with non-printed electric components associated with surface mounted components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SM20210390T 2012-09-26 2013-09-26 Metodi migliorati per l'acilazione di maytansinolo SMT202100390T1 (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261705731P 2012-09-26 2012-09-26
EP18213678.8A EP3486248B1 (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol

Publications (1)

Publication Number Publication Date
SMT202100390T1 true SMT202100390T1 (it) 2021-09-14

Family

ID=49328648

Family Applications (2)

Application Number Title Priority Date Filing Date
SM20210390T SMT202100390T1 (it) 2012-09-26 2013-09-26 Metodi migliorati per l'acilazione di maytansinolo
SM20190170T SMT201900170T1 (it) 2012-09-26 2013-09-26 Metodo migliorato per l'acilazione di maytansinolo

Family Applications After (1)

Application Number Title Priority Date Filing Date
SM20190170T SMT201900170T1 (it) 2012-09-26 2013-09-26 Metodo migliorato per l'acilazione di maytansinolo

Country Status (27)

Country Link
US (9) US9012629B2 (https=)
EP (3) EP3904358A1 (https=)
JP (7) JP6517693B2 (https=)
CN (2) CN104768955B (https=)
AU (4) AU2013323572B2 (https=)
BR (2) BR122021022582B1 (https=)
CA (2) CA2884873C (https=)
CY (2) CY1121415T1 (https=)
DK (2) DK2900676T3 (https=)
ES (2) ES2880754T3 (https=)
HR (2) HRP20190473T1 (https=)
HU (2) HUE043285T2 (https=)
IL (2) IL237899A (https=)
LT (2) LT2900676T (https=)
MX (2) MX366701B (https=)
MY (1) MY169250A (https=)
NZ (2) NZ739573A (https=)
PL (2) PL3486248T3 (https=)
PT (2) PT3486248T (https=)
RS (2) RS58493B1 (https=)
RU (2) RU2648992C2 (https=)
SG (1) SG11201501918UA (https=)
SI (2) SI3486248T1 (https=)
SM (2) SMT202100390T1 (https=)
TR (1) TR201903625T4 (https=)
WO (1) WO2014052537A1 (https=)
ZA (1) ZA201501898B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2900676T (lt) * 2012-09-26 2019-03-25 Immunogen, Inc. Maitanzinolio acilinimo patobulintas būdas
CN105585579A (zh) * 2014-10-24 2016-05-18 南京联宁生物制药有限公司 一种化合物及其制备方法以及美登素dm1的制备方法
JP6649961B2 (ja) * 2015-03-17 2020-02-19 レゲネロン ファーマシューティカルス,インコーポレーテッド アミノ酸アシル化試薬及びその使用方法
EP3554544A4 (en) 2016-12-16 2020-07-29 Bluefin Biomedicine, Inc. ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
DK3956332T3 (da) 2019-04-18 2023-05-01 Indena Spa Diasteroselektiv fremgangsmåde til fremstilling af thiol- eller disulfid-holdige maytansionidestere og mellemprodukter deraf
US12473579B2 (en) 2019-11-29 2025-11-18 Microbiopharm Japan Co., Ltd. Method for enzymatically producing maytansinol
EP4685150A1 (en) 2023-04-28 2026-01-28 Chugai Seiyaku Kabushiki Kaisha Method for producing amide group-containing compound using n-carboxyamino acid anhydride

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質c−15003
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
US4265814A (en) 1978-03-24 1981-05-05 Takeda Chemical Industries Matansinol 3-n-hexadecanoate
JPS5562090A (en) 1978-10-27 1980-05-10 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164687A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5566585A (en) 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS55164685A (en) 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US4309428A (en) 1979-07-30 1982-01-05 Takeda Chemical Industries, Ltd. Maytansinoids
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JP3054741B2 (ja) * 1989-09-29 2000-06-19 武田薬品工業株式会社 Tan―1313およびそのアシル誘導体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
AU775373B2 (en) * 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
TWI298067B (en) * 2002-01-31 2008-06-21 Daiso Co Ltd New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
PL3524611T3 (pl) * 2003-05-20 2021-06-14 Immunogen, Inc. Udoskonalone czynniki cytotoksyczne zawierające nowe maitansynoidy
CA2536378A1 (en) 2003-08-22 2005-03-10 Activbiotics, Inc. Rifamycin analogs and uses thereof
KR101270829B1 (ko) 2004-09-23 2013-06-07 제넨테크, 인크. 시스테인 유전자조작 항체 및 접합체
PL1819359T3 (pl) * 2004-12-09 2015-08-31 Janssen Biotech Inc Immunokoniugaty skierowane przeciw integrynie, metody ich wytwarzania oraz ich zastosowanie
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
WO2007021674A2 (en) 2005-08-09 2007-02-22 Millennium Pharmaceuticals, Inc. Method of acylating maytansinol with chiral amino acids
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2008288289A (ja) 2007-05-16 2008-11-27 Oki Electric Ind Co Ltd 電界効果トランジスタとその製造方法
BRPI1010620B8 (pt) 2009-06-03 2021-05-25 Immunogen Inc métodos de conjugação
WO2011051960A2 (en) * 2009-09-25 2011-05-05 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
JP5889912B2 (ja) * 2010-11-17 2016-03-22 ジェネンテック, インコーポレイテッド アラニニルメイタンシノール抗体コンジュゲート
LT2900676T (lt) 2012-09-26 2019-03-25 Immunogen, Inc. Maitanzinolio acilinimo patobulintas būdas

Also Published As

Publication number Publication date
US9796731B2 (en) 2017-10-24
US10461449B2 (en) 2019-10-29
CN104768955A (zh) 2015-07-08
RU2018109295A3 (https=) 2021-06-24
CA2884873A1 (en) 2014-04-03
RU2018109295A (ru) 2019-02-26
RU2015111635A (ru) 2016-11-20
BR112015006505B1 (pt) 2022-03-15
JP2022068367A (ja) 2022-05-09
NZ706019A (en) 2018-03-23
JP2018109044A (ja) 2018-07-12
US10100062B2 (en) 2018-10-16
CN108586487B (zh) 2021-11-05
TR201903625T4 (tr) 2019-04-22
EP3486248A1 (en) 2019-05-22
MX390615B (es) 2025-03-20
CY1124337T1 (el) 2022-07-22
WO2014052537A1 (en) 2014-04-03
AU2022201557A1 (en) 2022-03-31
JP2024010055A (ja) 2024-01-23
AU2018201392A1 (en) 2018-03-15
NZ739573A (en) 2019-11-29
PL3486248T3 (pl) 2021-10-25
CN108586487A (zh) 2018-09-28
AU2020203823A1 (en) 2020-07-02
JP2020117527A (ja) 2020-08-06
US20140142297A1 (en) 2014-05-22
AU2020203823B2 (en) 2021-12-09
EP3904358A1 (en) 2021-11-03
IL237899A (en) 2017-08-31
PT3486248T (pt) 2021-07-12
SMT201900170T1 (it) 2019-05-10
IL253988B (en) 2019-02-28
HK1212341A1 (en) 2016-06-10
PL2900676T3 (pl) 2019-06-28
JP6735000B1 (ja) 2020-08-05
US20240145953A1 (en) 2024-05-02
US20170137440A1 (en) 2017-05-18
HRP20211030T1 (hr) 2021-10-01
RS62075B1 (sr) 2021-07-30
BR112015006505A2 (pt) 2017-07-04
CY1121415T1 (el) 2020-05-29
PT2900676T (pt) 2019-03-29
JP6517693B2 (ja) 2019-05-22
DK3486248T3 (da) 2021-07-12
EP2900676A1 (en) 2015-08-05
RS58493B1 (sr) 2019-04-30
MX2019008652A (es) 2019-09-13
US10944190B2 (en) 2021-03-09
RU2765072C2 (ru) 2022-01-25
CA3133906A1 (en) 2014-04-03
ES2880754T3 (es) 2021-11-25
IL253988A0 (en) 2017-10-31
MY169250A (en) 2019-03-19
AU2013323572A1 (en) 2015-04-02
ZA201501898B (en) 2019-06-26
AU2018201392B2 (en) 2020-03-12
US9469655B2 (en) 2016-10-18
CN104768955B (zh) 2018-04-27
US20190013604A1 (en) 2019-01-10
LT2900676T (lt) 2019-03-25
HUE043285T2 (hu) 2019-08-28
SI3486248T1 (sl) 2021-10-29
US9012629B2 (en) 2015-04-21
JP2025098242A (ja) 2025-07-01
US20180099980A1 (en) 2018-04-12
AU2013323572B2 (en) 2017-12-07
EP2900676B1 (en) 2018-12-19
US20150191488A1 (en) 2015-07-09
BR122021022582B1 (pt) 2023-01-10
HUE055443T2 (hu) 2021-11-29
JP2020180150A (ja) 2020-11-05
SI2900676T1 (sl) 2019-04-30
CA2884873C (en) 2021-11-23
CA3133906C (en) 2023-05-02
MX366701B (es) 2019-07-22
EP3486248B1 (en) 2021-04-07
HRP20190473T1 (hr) 2019-05-03
SG11201501918UA (en) 2015-05-28
US20200153130A1 (en) 2020-05-14
US20240313444A1 (en) 2024-09-19
US20250007192A1 (en) 2025-01-02
LT3486248T (lt) 2021-08-25
MX2015003745A (es) 2015-06-24
JP2016500657A (ja) 2016-01-14
RU2648992C2 (ru) 2018-03-29
DK2900676T3 (en) 2019-04-08
ES2716561T3 (es) 2019-06-13

Similar Documents

Publication Publication Date Title
IL254311B (en) Centrifuge
ZA201503227B (en) Asymmetrical bisphosphite
IL237126A (en) Derivatives in cicadas
GB201217018D0 (en) Methods
IL235512A0 (en) New methods
SG11201502932TA (en) Compounds and methods for the production of suckerin and uses thereof
IL253988A0 (en) Acylation methods of maytansinol
GB201208874D0 (en) Methods
GB2507760B (en) Methods
HUP1200171A1 (hu) Módszerek polipeptidek elõállítására
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
GB201204280D0 (en) Methods
ZA201503833B (en) Method of hemoglobin-f determination
GB201209689D0 (en) Methods
GB201220686D0 (en) Methods
GB201208963D0 (en) Methods
GB201208756D0 (en) Methods
PL2934428T3 (pl) Sposób zwiększania wytrzymałości ceramik
AP2012000550S (en) E-horn methods
GB201216074D0 (en) Methods
GB201208875D0 (en) Methods
GB201207793D0 (en) Methods
GB201108637D0 (en) Dynamic range methods
HUE036665T2 (hu) Dihidro-pirido-oxazin származék szilárd formái